Jule Vasquez, MD Profile
Jule Vasquez, MD

@julefranve

Followers
317
Following
2K
Statuses
807

Oncologist at @NeoplasicasPeru. Lymphoma, MM, leukemia and HSCT. @ASCO IESG 20-24. HM Guideline Advisory Group. GCSRT and EWHC at Harvard Med 20-21. IDEA 2015.

Lima, Peru
Joined July 2011
Don't wanna be here? Send us removal request.
@julefranve
Jule Vasquez, MD
2 months
RT @gelamm_latam: Encuentro con pacientes y familia de pacientes, los esperamos!
Tweet media one
0
6
0
@julefranve
Jule Vasquez, MD
3 months
RT @CamiPenaO: APP GELAMM. Tiene sección para médicos y sección para pacientes. Podrán encontrar protocolos de tratamiento, guías, informac…
0
7
0
@julefranve
Jule Vasquez, MD
4 months
RT @Dr_AmerZeidan: In 2022, ⁦@ic_MDS⁩ issued a statement highlighting negative consequences of having 2 classifications for #MDSsm, we then…
0
10
0
@julefranve
Jule Vasquez, MD
4 months
RT @UsuarezMD: How I use Maintenance Therapy in Acute Myeloid Leukemia | Blood | American Society of Hematology
0
21
0
@julefranve
Jule Vasquez, MD
4 months
RT @UsuarezMD: How I Treat: Secondary Acute Myeloid Leukemia | Blood | American Society of Hematology
0
24
0
@julefranve
Jule Vasquez, MD
4 months
RT @UsuarezMD: Classification and risk stratification in T-lineage acute lymphoblastic leukemia | Blood | American Society of Hematology ht…
0
4
0
@julefranve
Jule Vasquez, MD
4 months
RT @RahulBanerjeeMD: #IMS24 repeat after me: PMD is NOT the same as EMD! Extramedullary dz in #MMsm does not touch any bone on any CT sli…
0
12
0
@julefranve
Jule Vasquez, MD
5 months
Happy for the opportunity to share our results on VTd as 1st line treatment in Peruvian MM Patients at INEN in #IMS24
Tweet media one
0
1
7
@julefranve
Jule Vasquez, MD
5 months
Counting down to #llmcongress2024! 📅 I'll be there to learn from world-class educators and engage in deep discussions on hematologic malignancies. Join me in NYC or online for this transformative event. Secure your spot today!
0
0
1
@julefranve
Jule Vasquez, MD
5 months
RT @smbenlazar: One of the best papers in the treatment of #ALL , in 2024 by @TalhaBadarMD , you can read this >>> Incorporation of imm…
0
29
0
@julefranve
Jule Vasquez, MD
5 months
RT @DrHKantarjian: Ponatinib and mini-hyperCVD w/ sequential blinatumomab is an effective combination for newly-diagnosed and R/R Philadelp…
0
30
0
@julefranve
Jule Vasquez, MD
5 months
RT @lymphomahub: CONGRESS | #SOHO2024 Stephen M Ansell, @MayoClinic, discusses whether ABVD and BEACOPP are still relevant for the treatmen…
0
14
0
@julefranve
Jule Vasquez, MD
5 months
RT @BloodJournal: How I diagnose and treat organizing pneumonia in hematopoietic cell transplant recipients #HowIT
0
27
0
@julefranve
Jule Vasquez, MD
5 months
RT @gelamm_latam: Renovamos nuestro compromiso y apoyo a los pacientes y familiares que conviven con mieloma múltiple…
0
3
0
@julefranve
Jule Vasquez, MD
5 months
RT @gelamm_latam: 5 de Septiembre. Día mundial contra el mieloma múltiple. Apoyemos, cuidemos y luchemos por nuestros pacientes. Camila Peñ…
0
7
0
@julefranve
Jule Vasquez, MD
6 months
RT @UsuarezMD: How I treat adult Ph-positive ALL | Blood | American Society of Hematology
0
23
0
@julefranve
Jule Vasquez, MD
6 months
RT @geltamo: Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results | Journal of Clinical Oncology https://…
0
6
0
@julefranve
Jule Vasquez, MD
6 months
0
0
0
@julefranve
Jule Vasquez, MD
6 months
@3bdullahM Thank you
0
0
0
@julefranve
Jule Vasquez, MD
6 months
1
0
0